Routine Molecular Screening of Patients with Advanced Non-SmallCell Lung Cancer in Circulating Cell-Free DNA at Diagnosis and During Progression Using OncoBEAMTM EGFR V2 and NGS Technologies.
Molecular Diagnosis & Therapy
Garcia, Jessica J; Gauthier, Arnaud A; Lescuyer, Gaëlle G; Barthelemy, David D; Geiguer, Florence F; Balandier, Julie J; Edelstein, Daniel L DL; Jones, Frederick S FS; Holtrup, Frank F; Duruisseau, Mickael M; Grolleau, Emmanuel E; Rodriguez-Lafrasse, Claire C; Merle, Patrick P; Couraud, Sébastien S; Payen, Léa L
Predictive Biomarkers for Immune Checkpoint Inhibitors in Metastatic Breast Cancer.
Cancer Medicine
Sivapiragasam, Abirami A; Ashok Kumar, Prashanth P; Sokol, Ethan S ES; Albacker, Lee A LA; Killian, Jonathan K JK; Ramkissoon, Shakti H SH; Huang, Richard S P RSP; Severson, Eric A EA; Brown, Charlotte A CA; Danziger, Natalie N; McGregor, Kimberly K; Ross, Jeffrey S JS
Ductal activation of oncogenic KRAS alone induces sarcomatoid phenotype.
Scientific Reports
Fu, Yong Y; Cruz-Monserrate, Zobeida Z; Helen Lin, H H; Chung, Yiyin Y; Ji, Baoan B; Lin, Szu-Min SM; Vonderfecht, Steven S; Logsdon, Craig D CD; Li, Chien-Feng CF; Ann, David K DK
Multiplex genomic profiling of non-small cell lung cancers from the LETS phase III trial of first-line S-1/carboplatin versus paclitaxel/carboplatin: results of a West Japan Oncology Group study.
Correlations of EGFR mutations and increases in EGFR and HER2 copy number to gefitinib response in a retrospective analysis of lung cancer patients.
Bmc Cancer
Pugh, Trevor J TJ; Bebb, Gwyn G; Barclay, Lorena L; Sutcliffe, Margaret M; Fee, John J; Salski, Chris C; O'Connor, Robert R; Ho, Cheryl C; Murray, Nevin N; Melosky, Barbara B; English, John J; Vielkind, Jeurgen J; Horsman, Doug D; Laskin, Janessa J JJ; Marra, Marco A MA